Akso Health Group
6 hedge funds and large institutions have $216K invested in Akso Health Group in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
6% more capital invested
Capital invested by funds: $203K → $216K (+$12.8K)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.01% less ownership
Funds ownership: 0.06% → 0.05% (-0.01%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$16.6K |
| 2 |
Renaissance Technologies
New York
|
-$14.8K |
| 3 |
Millennium Management
New York
|
-$12.2K |
| 4 |
CCG
Catalina Capital Group
Torrance,
California
|
-$1.44K |
AHG Hedge Fund Activity: Q3 2024 in Review
6 of the 6,969 institutional investors tracked by Wall St. Rank reported a position in Akso Health Group (AHG) for Q3 2024, worth a combined $216K — up 6.3% from $203K a quarter earlier.
Fund positioning in AHG was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 3 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $2.76K. The largest seller was UBS Group, cutting an estimated $16.6K.
- 6 institutional investors held Akso Health Group (AHG) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $216K of Akso Health Group stock for Q3 2024, up 6.3% quarter-over-quarter.
- 1 fund opened new Akso Health Group positions in Q3 2024 and 1 closed out, a net change of 0 holders.
- The largest Akso Health Group buyer in Q3 2024 was BlackRock, an estimated $2.76K added.
- The largest Akso Health Group seller in Q3 2024 was UBS Group, an estimated $16.6K sold.
Based on aggregated 13F filings for Q3 2024.